BRCA1/2+ (n=18) | BRCA1/2 VUS (n=15) | Non-BRCA1/2 (n=199) | |
---|---|---|---|
Age (years), mean (range) | 49.5 (40–75) | 64.8 (41–84) | 66.1 (28–89) |
BRCA1, n (%) | 12 (67) | 3 (20) | N/A |
BRCA2, n (%) | 6 (33) | 12 (80) | N/A |
Pathology, n | |||
High-grade serous | 15 | 11 | 166 |
Endometrioid | 1 | 4 | 15 |
Adenocarcinoma | 2 | 0 | 13 |
Mixed types | 0 | 0 | 5 |
Stage, n | |||
I | 4 | 5 | 25 |
II | 0 | 0 | 6 |
III | 12 | 9 | 112 |
IV | 2 | 1 | 39 |
Not classified | 0 | 0 | 15 |
VUS, variants of unknown significance.